Cargando…
Propranolol inhibits growth of hemangioma-initiating cells but does not induce apoptosis
BACKGROUND: Infantile hemangioma (IH) is the most common tumor of infancy. The first-line therapy for IH is propranolol, a non-selective β-adrenergic receptor antagonist. However, mechanisms for the therapeutic effect of propranolol and regrowth of IH following cessation of treatment in some cases a...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3951485/ https://www.ncbi.nlm.nih.gov/pubmed/24296797 http://dx.doi.org/10.1038/pr.2013.231 |